Reconsidering the scope of US state laws allowing pharmacist substitution of generic drugs

BMJ. 2020 Jun 23;369:m2236. doi: 10.1136/bmj.m2236.
No abstract available

MeSH terms

  • Drug Costs / legislation & jurisprudence*
  • Drug Substitution*
  • Drugs, Generic* / economics
  • Humans
  • Legislation, Pharmacy
  • Pharmacists / legislation & jurisprudence*
  • Therapeutic Equivalency
  • United States

Substances

  • Drugs, Generic